News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Amgen (AMGN) Venture Capital Funds Early-Stage Biotechs


11/15/2011 8:15:27 AM

When Amgen Inc. (AMGN), the world’s largest biotechnology firm, decided that heart drugs being developed by startup MiRagen Therapeutics Inc. were too risky for a partnership deal, the company didn’t just walk away. Instead, Amgen turned to its venture capital arm to help fund the 4-year-old company. While Amgen has cut research spending, the Thousand Oaks, California-based biotech says its venture fund has invested in 26 companies since starting with $100 million in 2004.

Read at Bloomberg
Read at SF Gate


comments powered by Disqus
Bloomberg
SF Gate
Amgen
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES